IMPLICATIONS FOR PATIENT CARE: Our results improve the utility of 18F-PI-2620 to quantify tau burden, which will improve the clinical application of 18F-PI-2620 in the differential diagnosis of tauopathies. This evidence concerns the gene MAPT and tauopathy.